[The place of isotopic exploration in the evaluation of anti-anginal drugs].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000787:Angina Pectoris / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000818:Animals; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D003327:Coronary Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000503:physiopathology; D004176:Dipyridamole / Q000008:administration & dosage; D004285:Dogs; D006321:Heart / Q000000981:diagnostic imaging*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage; D005996:Nitroglycerin / Q000008:administration & dosage; D011868:Radioisotopes; D013667:Technetium; D013793:Thallium; D014055:Tomography, Emission-Computed; D014980:Xenon Radioisotopes
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D011868:Radioisotopes; D014980:Xenon Radioisotopes; D004176:Dipyridamole; D013667:Technetium; D013793:Thallium; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate
La place des explorations isotopiques dans l'évaluation des médications anti-angineuses.